Best TRT Clinics in 2026 — Ranked & Reviewed
Testosterone replacement therapy is a legitimate treatment for clinically diagnosed hypogonadism — and one of the most aggressively marketed categories in men's telehealth, where the line between real symptom relief and overprescribing blurs easily. We ranked TRT clinics on diagnostic rigor (does the intake require two morning testosterone measurements below 300 ng/dL plus symptoms, per the Endocrine Society's 2018 guideline, rather than a single test or a questionnaire), ongoing lab monitoring (hematocrit and PSA at baseline, 3, 6, and 12 months), formulary breadth (injectable, gel, or fertility-preserving options like enclomiphene), and transparent pricing. We do not rank clinics that prescribe testosterone on a symptom checklist alone.
Lowest verified price: $13/mo4 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
4 trt clinics compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
compounded or brand GLP-1 bundled with TRT and peptides for men
From /mo$100Flat at every doseCoverage47 statesMedicationsTestosterone named-clinician TRT, ED and thyroid care with an in-house CLIA lab
From /mo$65Coverage41 statesMedicationsTestosteroneClomipheneconcierge TRT telehealth with weekly testosterone injections
From /mo$149Coverage35 statesMedicationsTestosteroneEnclomiphene- Best Budget
all-inclusive TRT, ED and peptide care backed by OpenLoop Health
From /mo$13CoverageCheck intakeMedicationsTestosteroneEnclomiphene
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick compounded or brand GLP-1 bundled with TRT and peptides for men | $100 Flat pricing | Testosterone | 47 states | Visit → | |
 named-clinician TRT, ED and thyroid care with an in-house CLIA lab | $65 | TestosteroneClomiphene | 41 states | Visit → | |
 concierge TRT telehealth with weekly testosterone injections | $149 | TestosteroneEnclomiphene | 35 states | Visit → | |
Best Budget all-inclusive TRT, ED and peptide care backed by OpenLoop Health | $13 | TestosteroneEnclomiphene | Check intake | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Brightmeds
Verified partnerBest for: compounded or brand GLP-1 bundled with TRT and peptides for men
Brightmeds is a multi-vertical telehealth platform bundling GLP-1 weight loss, TRT for men, and longevity peptides (sermorelin, NAD+, glutathione) under one membership. It offers both compounded GLP-1s — including microdosing protocols — and brand-name Zepbound pens and vials, a rare dual-modality mix. Compounded semaglutide starts at $189/mo and tirzepatide at $289/mo, flat-priced across doses; ongoing renewal pricing isn’t published before the intake quiz. Available in 47 states.
Score Breakdown
Pros
- ✓One login covers GLP-1, TRT, peptides, and longevity — convenient for men exploring weight loss and hormones
- ✓Offers both compounded GLP-1s and brand-name FDA-approved Zepbound (pens and vials)
- ✓Microdosing protocols available for compounded semaglutide and tirzepatide
- ✓Publishes the FDA compounded-medication disclaimer with explicit 503A and 503B facility mention
- ✓Dispensing pharmacies named in Terms (Beaker Pharmacy and Red Rock Pharmacy)
- ✓Free baseline labs for TRT clients, and a money-back guarantee if not approved
- ✓47-state footprint (excludes AL, AR, MS) — broader than most TRT-focused platforms
- ✓Tirzepatide is flat-priced across all doses (starting at $289/mo) — no extra cost as you titrate up
Cons
- ✗Pricing isn't itemized on the main pages — you must click through to landers or the application flow
- ✗Brand-name Zepbound carries a separate $100 doctor consult fee on top of drug cost
- ✗No LegitScript certification mentioned on the site
- ✗Named medical director not disclosed
- ✗Trustpilot rating not independently audited
- ✗Multi-vertical bundling can distract patients who only want GLP-1
- ✗Ongoing renewal pricing was removed from the landers — only 'starting at' $189 (sema) and $289 (tirz) first-month prices are published
Male Excel
Best for: named-clinician TRT, ED and thyroid care with an in-house CLIA lab
Male Excel (Male Excel Inc. dba Excel Medical) is a Charlotte, NC men's-health telehealth practice offering testosterone replacement therapy, ED treatment, and bioidentical thyroid care — not GLP-1 or weight loss. It stands out for an in-house CLIA-certified lab, named clinical leadership, and 30+ listed prescribers. TRT starts at $120/month plus a required $99/month membership and one-time $99 consult; available in 41 states.
Score Breakdown
Pros
- ✓Operating entity disclosed: Male Excel Inc. dba Excel Medical, Charlotte NC, governed by North Carolina law
- ✓Named clinical leadership: Peter Fotinos MD (CMO) and Lorna Brudie DO (Medical Director) with verifiable credentials
- ✓30+ individual prescribers named on the site — high transparency for TRT telehealth
- ✓In-house CLIA-certified lab with initial and 6-month follow-up labs in the $99/mo membership
- ✓Itemized starting prices published with supply duration and dose strengths
- ✓LegitScript certification displayed in the footer
- ✓Operating since 2019 with sister brand FemExcel
- ✓Wide coverage (41 states) with a clear excluded-state list
Cons
- ✗Outside the GLP-1/weight-loss scope — TRT, ED, thyroid, and peptide therapy only, no semaglutide or tirzepatide
- ✗Binding Terms state all sales are final and non-refundable, overriding the marketing's 90-day refund claim
- ✗True cost stacks membership + consult + medication — roughly $219 first month and $219/mo recurring, above the $120 headline
- ✗Triclozene (clomiphene) is off-label for male hypogonadism — legal but not FDA-evaluated for that use
- ✗Pricing page doesn't say whether testosterone injection and cream are FDA-approved or compounded — confirm at intake
- ✗Pharmacy partner not named, making licensure verification difficult before purchase
- ✗Thyroid pricing not separately disclosed — only 'included when clinically appropriate'
- ✗'100,000+ patients' and 'nearly two decades' marketing claims are unaudited and conflict with the 2019 launch
Feel30
Best for: concierge TRT telehealth with weekly testosterone injections
Feel30 (operated by F3 Health) is an Austin-based concierge telehealth brand focused on testosterone replacement therapy, not GLP-1 weight loss. It offers weekly injectable testosterone cypionate, oral enclomiphene, and sermorelin under an all-inclusive subscription. Headline pricing is $149/mo for testosterone (plus a $99 initial lab and evaluation fee), with TRT in roughly 35 states and enclomiphene nationwide.
Score Breakdown
Pros
- ✓Operating entity disclosed: F3 Health Inc (operating as Feel30), based in Austin, TX
- ✓Founder named: Thomas Phillips; clinical consultant named: Anneliese Cadena, AGNP-C
- ✓Headline product (testosterone cypionate) is a long-established FDA-approved drug with decades of safety data
- ✓Itemized pricing on every product page, with subscription vs regular price shown ($149/mo vs $399.99)
- ✓Upfront $99 lab-panel and medical-evaluation fee disclosed, not buried at checkout
- ✓Full hormone panel: total T, free T, SHBG, plus 10 more markers and vitamin D
- ✓Quarterly at-home nurse phlebotomy — differentiated vs competitors requiring lab-center visits
- ✓Clear refund-on-disqualification and cancel-anytime (72-hour notice) policies
Cons
- ✗TRT-only — not a GLP-1 or weight-loss provider; testosterone is not indicated for weight loss
- ✗Pharmacy partner not named — only 'licensed U.S. pharmacies' generically
- ✗Lab partner not named for the at-home phlebotomy or panel processing
- ✗No MD/DO medical director named for oversight of a Schedule III controlled substance
- ✗Testosterone cypionate is DEA Schedule III — controlled-substance telehealth disclosures aren't addressed
- ✗Sermorelin and ED-medication pricing shown as placeholders, not transparent pre-quiz
- ✗No money-back window once a prescription is ordered
- ✗New company (launched Dec 2025) — limited operating history and no BBB profile yet
Taurus Meds
Best for: all-inclusive TRT, ED and peptide care backed by OpenLoop Health
Taurus Meds is a direct-to-consumer telehealth platform for testosterone replacement therapy (TRT), ED and peptide care — not a GLP-1 or weight-loss provider. It offers injectable testosterone cypionate, oral enclomiphene and testosterone gel through a $49 first-month consult plus a $149/mo all-inclusive subscription bundling the visit, medication and shipping. Clinical care runs through OpenLoop Health, with LabCorp and Quest handling the baseline draw.
Score Breakdown
Pros
- ✓Legal entity disclosed (Taurus Medical, Inc., Delaware) in the Terms of Service
- ✓Named MSO partner OpenLoop Health — an established telehealth clinician network
- ✓Four named compounding pharmacy partners: RedRock, Health Warehouse, Precision, and Triad Rx
- ✓Named lab partners LabCorp and Quest for baseline testosterone testing
- ✓All-inclusive flat $149/mo TRT pricing covers oversight, medication, and shipping
- ✓Multiple TRT modalities: injectable cypionate, oral enclomiphene, and topical gel
- ✓90-day money-back guarantee — unusual for a TRT provider
- ✓LegitScript verification badge in footer
Cons
- ✗TRT-only — not a GLP-1 or weight-loss provider; only tangentially related to weight loss
- ✗State availability not stated — gated behind the intake form
- ✗Exact medication doses not disclosed before prescription
- ✗Refund policy contradicts the 90-day guarantee — Terms say shipped medications and lab tests are final-sale
- ✗Compounded ED and peptide products are FDA-unapproved with undisclosed ingredients
- ✗Product cards repeat the same injection claim across oral and topical products — an unreviewed copy error
- ✗Operating address is a Delaware private mailbox, not a working office; support hours and phone not listed
How to choose a TRT clinic
TRT is a legitimate medical therapy with a real diagnostic bar — not a supplement or a lifestyle upgrade. The providers worth paying for actually check that bar before prescribing and keep monitoring you afterward.
What to look for
- A real diagnostic workup, not a questionnaire. The Endocrine Society standard requires two separate morning total-testosterone measurements below 300 ng/dL plus consistent symptoms before a diagnosis of hypogonadism. A clinic that prescribes off a single test, an afternoon draw, or a symptom checklist alone is prescribing outside the guideline.
- Ongoing lab monitoring. Hematocrit and PSA should be checked at baseline, 3 months, 6 months, and then annually — hematocrit above 50% warrants a dose reduction. A clinic that labs you once and never again is skipping the part of TRT that actually prevents harm.
- Formulary and fertility trade-offs. Injectable cypionate is cheapest and most common; gel avoids needles but carries transfer risk; enclomiphene raises endogenous testosterone without suppressing fertility. If you're planning to have children, the clinic should discuss this before you start.
Red flags to avoid
- Prescribing on a questionnaire alone. No diagnosis of low testosterone is defensible without two morning lab draws below 300 ng/dL plus symptoms. A clinic that skips the second confirmatory test is a pellet-mill pattern, not a medical workup.
- No hematocrit or PSA monitoring after the first script. TRT raises red blood cell mass and can accelerate an undiagnosed prostate condition. A clinic that doesn't recheck labs at 3, 6, and 12 months is not managing the therapy — it's just refilling it.
- Pellets pushed on a new patient. Pellet implants can't have their dose reduced once placed — if hematocrit or PSA rises, your only options are to wait it out or have them surgically removed. That makes pellets a poor first modality before your response to TRT is known.
- No named clinical team or monitoring cadence. A site that won't say who's prescribing or how often it re-checks labs is a transparency gap you should treat as disqualifying for a therapy with real cardiovascular and hematologic monitoring requirements.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.